Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

ALZN

ALZN News

Newswire

16:35

Alzamend Neuro Director McGrath Lynne Fahey Sells 30 Shares at $2.29/Share on 2025-10-23.

07:20

Alzamend Neuro Insider Sells $344,222 Worth of Shares According to SEC Filing

08:17

Alzamend Neuro: Ascendiant Capital Maintains Buy, PT Down to $42 from $45

16:10

Alzamend Neuro (ALZN) Price Target Lowered to $45.00; Buy Rating Maintained

06:01

Alzamend Neuro: Ascendiant Capital lowers PT to $45, maintains Buy rating.

View More

About ALZN

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More